# Cal-Maine Foods Inc: financial statements, quarterly CALM · Nasdaq · CIK 16160 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends May 29 Pages: [Overview](/companies/calm.md) · [Financials](/companies/calm/financials.md) · [Filings](/companies/calm/filings.md) · [Insiders](/companies/calm/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/calm/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | Q4 FY2024 (2024-06-01) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-30) | Q1 FY2027 (2026-08-29) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [523](/filings/0001562762-25-000004.md) | [703](/filings/0001562762-25-000084.md) | [641](/filings/0001562762-24-000177.md) | [786](/filings/0001562762-25-000251.md) | [955](/filings/0001562762-26-000004.md) | [1,418](/filings/0001562762-26-000046.md) | [1,104 d](/filings/0001562762-26-000080.md) | [923](/filings/0001562762-26-000113.md) | [769](/filings/0001562762-26-000004.md) | [667](/filings/0001562762-26-000046.md) | [553 d](/filings/0001562762-26-000080.md) | [540](/filings/0001562762-26-000113.md) | | Cost of revenue | $m | [432](/filings/0001562762-25-000004.md) | [485](/filings/0001562762-25-000084.md) | [454 d](/filings/0001562762-26-000080.md) | [539](/filings/0001562762-25-000251.md) | [599](/filings/0001562762-26-000004.md) | [702](/filings/0001562762-26-000046.md) | [572 d](/filings/0001562762-26-000080.md) | [611](/filings/0001562762-26-000113.md) | [562](/filings/0001562762-26-000004.md) | [548](/filings/0001562762-26-000046.md) | [519 d](/filings/0001562762-26-000080.md) | [539](/filings/0001562762-26-000113.md) | | Gross profit | $m | [91.1](/filings/0001562762-25-000004.md) | [219](/filings/0001562762-25-000084.md) | [186 d](/filings/0001562762-26-000080.md) | [247](/filings/0001562762-25-000251.md) | [356](/filings/0001562762-26-000004.md) | [716](/filings/0001562762-26-000046.md) | [532 d](/filings/0001562762-26-000080.md) | [311](/filings/0001562762-26-000113.md) | [207](/filings/0001562762-26-000004.md) | [119](/filings/0001562762-26-000046.md) | [34.1 d](/filings/0001562762-26-000080.md) | [0.4](/filings/0001562762-26-000113.md) | | Selling, general and administrative | $m | [76.6](/filings/0001562762-25-000004.md) | [66.0](/filings/0001562762-25-000084.md) | [57.8 d](/filings/0001562762-26-000080.md) | [61.9](/filings/0001562762-25-000251.md) | [77.6](/filings/0001562762-26-000004.md) | [80.0](/filings/0001562762-26-000046.md) | [94.9 d](/filings/0001562762-26-000080.md) | [69.5](/filings/0001562762-26-000113.md) | [82.9](/filings/0001562762-26-000004.md) | [83.3](/filings/0001562762-26-000046.md) | [93.6 d](/filings/0001562762-26-000080.md) | [81.7](/filings/0001562762-26-000113.md) | | Operating income | $m | [14.2](/filings/0001562762-25-000004.md) | [163](/filings/0001562762-25-000084.md) | [142 d](/filings/0001562762-26-000080.md) | [187](/filings/0001562762-25-000251.md) | [278](/filings/0001562762-26-000004.md) | [636](/filings/0001562762-26-000046.md) | [436 d](/filings/0001562762-26-000080.md) | [249](/filings/0001562762-26-000113.md) | [124](/filings/0001562762-26-000004.md) | [35.9](/filings/0001562762-26-000046.md) | [(58.8) d](/filings/0001562762-26-000080.md) | [(82.2)](/filings/0001562762-26-000113.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [5.5](/filings/0001562762-25-000004.md) | [38.8](/filings/0001562762-25-000084.md) | [39.0 d](/filings/0001562762-26-000080.md) | [48.4](/filings/0001562762-25-000251.md) | [70.6](/filings/0001562762-26-000004.md) | [155](/filings/0001562762-26-000046.md) | [111 d](/filings/0001562762-26-000080.md) | [64.2](/filings/0001562762-26-000113.md) | [33.2](/filings/0001562762-26-000004.md) | [7.1](/filings/0001562762-26-000046.md) | [(11.5) d](/filings/0001562762-26-000080.md) | [(18.0)](/filings/0001562762-26-000113.md) | | Net income | $m | [17.0](/filings/0001562762-25-000004.md) | [147](/filings/0001562762-25-000084.md) | [113 d](/filings/0001562762-26-000080.md) | [150](/filings/0001562762-25-000251.md) | [219](/filings/0001562762-26-000004.md) | [509](/filings/0001562762-26-000046.md) | [342 d](/filings/0001562762-26-000080.md) | [199](/filings/0001562762-26-000113.md) | [103](/filings/0001562762-26-000004.md) | [50.5](/filings/0001562762-26-000046.md) | [(35.9) d](/filings/0001562762-26-000080.md) | [(58.6)](/filings/0001562762-26-000113.md) | | Diluted EPS | $ per share | [0.35](/filings/0001562762-25-000004.md) | [3.00](/filings/0001562762-25-000084.md) | not reported | [3.06](/filings/0001562762-25-000251.md) | [4.47](/filings/0001562762-26-000004.md) | [10.38](/filings/0001562762-26-000046.md) | not reported | [4.12](/filings/0001562762-26-000113.md) | [2.13](/filings/0001562762-26-000004.md) | [1.06](/filings/0001562762-26-000046.md) | not reported | [(1.26)](/filings/0001562762-26-000113.md) | | Basic EPS | $ per share | [0.35](/filings/0001562762-25-000004.md) | [3.01](/filings/0001562762-25-000084.md) | not reported | [3.08](/filings/0001562762-25-000251.md) | [4.49](/filings/0001562762-26-000004.md) | [10.42](/filings/0001562762-26-000046.md) | not reported | [4.13](/filings/0001562762-26-000113.md) | [2.14](/filings/0001562762-26-000004.md) | [1.07](/filings/0001562762-26-000046.md) | not reported | [(1.26)](/filings/0001562762-26-000113.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | FY2024 (2024-06-01) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | FY2025 (2025-05-31) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | FY2026 (2026-05-30) | Q1 FY2027 (2026-08-29) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [362](/filings/0001562762-24-000004.md) | [367](/filings/0001562762-24-000077.md) | [238](/filings/0001562762-25-000170.md) | [182](/filings/0001562762-24-000230.md) | [140](/filings/0001562762-25-000004.md) | [497](/filings/0001562762-25-000084.md) | [499](/filings/0001562762-26-000080.md) | [252](/filings/0001562762-25-000251.md) | [369](/filings/0001562762-26-000004.md) | [392](/filings/0001562762-26-000046.md) | [107](/filings/0001562762-26-000113.md) | [114](/filings/0001562762-26-000113.md) | | Current assets | $m | [1,064](/filings/0001562762-24-000004.md) | [1,218](/filings/0001562762-24-000077.md) | [1,242](/filings/0001562762-25-000170.md) | [1,343](/filings/0001562762-24-000230.md) | [1,425](/filings/0001562762-25-000004.md) | [1,983](/filings/0001562762-25-000084.md) | [1,968](/filings/0001562762-26-000080.md) | [1,847](/filings/0001562762-25-000251.md) | [1,754](/filings/0001562762-26-000004.md) | [1,749](/filings/0001562762-26-000046.md) | [1,582](/filings/0001562762-26-000113.md) | [1,472](/filings/0001562762-26-000113.md) | | Total assets | $m | [1,967](/filings/0001562762-24-000004.md) | [2,134](/filings/0001562762-24-000077.md) | [2,185](/filings/0001562762-25-000170.md) | [2,390](/filings/0001562762-24-000230.md) | [2,490](/filings/0001562762-25-000004.md) | [3,082](/filings/0001562762-25-000084.md) | [3,085](/filings/0001562762-26-000080.md) | [3,196](/filings/0001562762-25-000251.md) | [3,144](/filings/0001562762-26-000004.md) | [3,139](/filings/0001562762-26-000046.md) | [3,108](/filings/0001562762-26-000113.md) | [3,013](/filings/0001562762-26-000113.md) | | Current liabilities | $m | [154](/filings/0001562762-24-000004.md) | [216](/filings/0001562762-24-000077.md) | [228](/filings/0001562762-25-000170.md) | [325](/filings/0001562762-24-000230.md) | [261](/filings/0001562762-25-000004.md) | [514](/filings/0001562762-25-000084.md) | [308](/filings/0001562762-26-000080.md) | [270](/filings/0001562762-25-000251.md) | [219](/filings/0001562762-26-000004.md) | [213](/filings/0001562762-26-000046.md) | [206](/filings/0001562762-26-000113.md) | [191](/filings/0001562762-26-000113.md) | | Total liabilities | $m | [343](/filings/0001562762-24-000004.md) | [413](/filings/0001562762-24-000077.md) | [388](/filings/0001562762-25-000170.md) | [491](/filings/0001562762-24-000230.md) | [439](/filings/0001562762-25-000004.md) | [694](/filings/0001562762-25-000084.md) | [519](/filings/0001562762-26-000080.md) | [494](/filings/0001562762-25-000251.md) | [446](/filings/0001562762-26-000004.md) | [432](/filings/0001562762-26-000046.md) | [467](/filings/0001562762-26-000113.md) | [433](/filings/0001562762-26-000113.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [1,626](/filings/0001562762-24-000004.md) | [1,724](/filings/0001562762-24-000077.md) | [1,800](/filings/0001562762-25-000170.md) | [1,903](/filings/0001562762-24-000230.md) | [2,045](/filings/0001562762-25-000004.md) | [2,382](/filings/0001562762-25-000084.md) | [2,561](/filings/0001562762-26-000080.md) | [2,697](/filings/0001562762-25-000251.md) | [2,691](/filings/0001562762-26-000004.md) | [2,700](/filings/0001562762-26-000046.md) | [2,633](/filings/0001562762-26-000113.md) | [2,570](/filings/0001562762-26-000113.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | Q4 FY2024 (2024-06-01) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-30) | Q1 FY2027 (2026-08-29) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [50.0 d](/filings/0001562762-25-000004.md) | [164 d](/filings/0001562762-25-000084.md) | [214 d](/filings/0001562762-26-000080.md) | [117](/filings/0001562762-25-000251.md) | [123 d](/filings/0001562762-26-000004.md) | [572 d](/filings/0001562762-26-000046.md) | [413 d](/filings/0001562762-26-000080.md) | [279](/filings/0001562762-26-000113.md) | [94.8 d](/filings/0001562762-26-000004.md) | [104 d](/filings/0001562762-26-000046.md) | [2.8 d](/filings/0001562762-26-000080.md) | [(101)](/filings/0001562762-26-000113.md) | | Capital expenditure | $m | [39.1 d](/filings/0001562762-25-000004.md) | [30.2 d](/filings/0001562762-25-000084.md) | [51.1 d](/filings/0001562762-26-000080.md) | [35.8](/filings/0001562762-25-000251.md) | [29.8 d](/filings/0001562762-26-000004.md) | [49.8 d](/filings/0001562762-26-000046.md) | [45.9 d](/filings/0001562762-26-000080.md) | [45.3](/filings/0001562762-26-000113.md) | [46.8 d](/filings/0001562762-26-000004.md) | [31.6 d](/filings/0001562762-26-000046.md) | [27.5 d](/filings/0001562762-26-000080.md) | [26.6](/filings/0001562762-26-000113.md) | | Dividends paid | $m | [0.3 d](/filings/0001562762-25-000004.md) | [5.7 d](/filings/0001562762-25-000084.md) | [48.9 d](/filings/0001562762-26-000080.md) | [37.8](/filings/0001562762-25-000251.md) | [50.0 d](/filings/0001562762-26-000004.md) | [73.0 d](/filings/0001562762-26-000046.md) | [169 d](/filings/0001562762-26-000080.md) | [114](/filings/0001562762-26-000113.md) | [66.4 d](/filings/0001562762-26-000004.md) | [34.3 d](/filings/0001562762-26-000046.md) | [16.8 d](/filings/0001562762-26-000080.md) | [0.0](/filings/0001562762-26-000113.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: not reported ## Shares | Line item | Unit | Q2 FY2023 (2022-11-26) | Q3 FY2023 (2023-02-25) | Q1 FY2024 (2023-09-02) | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | Q1 FY2027 (2026-08-29) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [48.8](/filings/0001562762-24-000004.md) | [48.8](/filings/0001562762-24-000077.md) | [48.8](/filings/0001562762-24-000230.md) | [48.9](/filings/0001562762-25-000004.md) | [48.9](/filings/0001562762-25-000084.md) | [48.9](/filings/0001562762-25-000251.md) | [49.0](/filings/0001562762-26-000004.md) | [49.0](/filings/0001562762-26-000046.md) | [48.4](/filings/0001562762-26-000113.md) | [48.2](/filings/0001562762-26-000004.md) | [47.4](/filings/0001562762-26-000046.md) | [46.7](/filings/0001562762-26-000113.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 46,710,613 at 2026-09-30, from the cover of the [10-Q filed 2026-09-30](/filings/0001562762-26-000113.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.